4-Methoxybenzoyl chloride | CAS:100-07-2

We serve 4-Methoxybenzoyl chloride CAS:100-07-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Methoxybenzoyl chloride

CAS No: 100-07-2
Product Name: 4-Methoxybenzoyl chloride
Other Name:
4-Methoxybenzoyl chloride
p-Anisoyl chloride
p-Methoxybenzoyl chloride
para-methoxybenzoyl chloride
4-Methoxybenzoic acid chloride
m-methylbenzoyl chloride
4-methoxyphenylcarbonyl chloride
 
Density: 1.2±0.1 g/cm3
Boiling Point: 263.2±13.0 °C at 760 mmHg
Melting Point: 22 °C(lit.)
Molecular Formula: C8H7ClO2
Molecular Weight: 170.593
Flash Point: 87.8±0.0 °C
Exact Mass: 170.013458
PSA: 26.30000
LogP: 2.38
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.530
Stability: Stable, but reacts violently with water. Ensure no moisture enters the container in which this material is stored, to prevent pressure build-up. Incompatible with water, moisture, strong bases, strong oxidizing agents.
 
Specification
Appearance: Colorless transparent liquid or solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Amiodarone hydrochloride CAS: 19774-82-4.
Be used as pharmaceutical intermediate, mainly used to synthesize myocardial infarction and angina pectoris Amiodarone hydrochloride.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 4-Methoxybenzoyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methoxyphenylcarbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-Methoxybenzoyl chloride Use and application,p-Anisoyl chloride technical grade,usp/ep/jp grade.


Related News: Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.3-Methyl-1-butanethiol manufacturer Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.4-Chloro-6-iodoquinazoline supplier Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.D-Lysine Monohydrochloride vendor This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings.